Class I
Ongoing
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Why: Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
- Company
- SoloVital
Chula Vista, CA, United States - Reported
- Aug 7, 2024
- Recall started
- Jul 12, 2024
- Where sold
- Nationwide within the United States
- Amount
- 1,331 bottles
- Full product description
- Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
- Lots / codes affected
- All lots within Expiry
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.